Back
Apellis Pharmaceuticals Vs. MicroSectors™ FANG+™ 3X Leveraged ETN Industry Stock Comparison
Sell
27
APLS
Apellis Pharmaceuticals
Last Price:
35.83
Seasonality Move:
15.53%
Buy
62
FNGU
MicroSectors™ FANG+™ 3X Leveraged ETN
Last Price:
382.82
Seasonality Move:
0.58%
Sell
27
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $37.62. The Score for APLS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
MicroSectors™ FANG+™ 3X Leveraged ETN (FNGU)
is a Buy
Is MicroSectors™ FANG+™ 3X Leveraged ETN a Buy, Sell or Hold?
- The current MicroSectors™ FANG+™ 3X Leveraged ETN [FNGU] share price is $394.00. The Score for FNGU is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- FNGU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $37.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.
FNGU Stock Price Chart
What is MicroSectors™ FANG+™ 3X Leveraged ETN's stock price today?
-
The MicroSectors™ FANG+™ 3X Leveraged ETN share price today is $394.00
The current trend is relatively stagnant and FNGU is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 46.63 | Sell |
| Chaikin Money Flow: | 246806 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.06 - 39.78) | Sell |
| Bollinger Bands (100): | (36.75 - 43.51) | Sell |
FNGU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.98 | Sell |
| Relative Strength Index (14 RSI): | 53.9 | Buy |
| Chaikin Money Flow: | 569891 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (347.65 - 407.95) | Buy |
| Bollinger Bands (100): | (324.57 - 451.63) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.76 | Sell |
| 20-day SMA: | 38.9 | Sell |
| 50-day SMA: | 38.09 | Sell |
| 200-day SMA: | 50.5 | Sell |
| 8-day EMA: | 38.4 | Sell |
| 20-day EMA: | 38.51 | Sell |
| 50-day EMA: | 38.9 | Sell |
| 200-day EMA: | 46.23 | Sell |
FNGU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 357.04 | Buy |
| 20-day SMA: | 380.05 | Buy |
| 50-day SMA: | 403.66 | Sell |
| 200-day SMA: | 333.32 | Buy |
| 8-day EMA: | 369.18 | Buy |
| 20-day EMA: | 372.09 | Buy |
| 50-day EMA: | 384.66 | Buy |
| 200-day EMA: | 335.17 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.
MicroSectors™ FANG+™ 3X Leveraged ETN Earnings Growth & FNGU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MicroSectors™ FANG+™ 3X Leveraged ETN Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||